137 related articles for article (PubMed ID: 2171541)
1. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis.
Klareskog L; Gustafsson R; Scheynius A; Hällgren R
Arthritis Rheum; 1990 Oct; 33(10):1534-41. PubMed ID: 2171541
[TBL] [Abstract][Full Text] [Related]
2. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.
Yamakage A; Kikuchi K; Smith EA; LeRoy EC; Trojanowska M
J Exp Med; 1992 May; 175(5):1227-34. PubMed ID: 1314885
[TBL] [Abstract][Full Text] [Related]
3. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis.
Krane JF; Murphy DP; Gottlieb AB; Carter DM; Hart CE; Krueger JG
J Invest Dermatol; 1991 Jun; 96(6):983-6. PubMed ID: 1646268
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma.
Zheng XY; Zhang JZ; Tu P; Ma SQ
J Dermatol Sci; 1998 Nov; 18(2):90-7. PubMed ID: 9833975
[TBL] [Abstract][Full Text] [Related]
5. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
[TBL] [Abstract][Full Text] [Related]
6. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
[TBL] [Abstract][Full Text] [Related]
7. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
8. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
[TBL] [Abstract][Full Text] [Related]
9. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans.
Reuterdahl C; Sundberg C; Rubin K; Funa K; Gerdin B
J Clin Invest; 1993 May; 91(5):2065-75. PubMed ID: 8486774
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
[TBL] [Abstract][Full Text] [Related]
11. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
13. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma.
Gay S; Jones RE; Huang GQ; Gay RE
J Invest Dermatol; 1989 Feb; 92(2):301-3. PubMed ID: 2918236
[TBL] [Abstract][Full Text] [Related]
14. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis.
Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P
Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913
[TBL] [Abstract][Full Text] [Related]
15. Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation.
Rubin K; Terracio L; Rönnstrand L; Heldin CH; Klareskog L
Scand J Immunol; 1988 Mar; 27(3):285-94. PubMed ID: 2451272
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
[TBL] [Abstract][Full Text] [Related]
17. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.
Chaudhry A; Papanicolaou V; Oberg K; Heldin CH; Funa K
Cancer Res; 1992 Feb; 52(4):1006-12. PubMed ID: 1310635
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
[TBL] [Abstract][Full Text] [Related]
19. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease.
Koch AE; Kronfeld-Harrington LB; Szekanecz Z; Cho MM; Haines GK; Harlow LA; Strieter RM; Kunkel SL; Massa MC; Barr WG
Pathobiology; 1993; 61(5-6):239-46. PubMed ID: 7507681
[TBL] [Abstract][Full Text] [Related]
20. Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium.
Reuterdahl C; Tingström A; Terracio L; Funa K; Heldin CH; Rubin K
Lab Invest; 1991 Mar; 64(3):321-9. PubMed ID: 1848332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
